Smoking does not influence disability accumulation in primary progressive multiple sclerosis

Background and purpose The modifiable risk factor cigarette smoking has been associated with an increased risk of developing multiple sclerosis (MS) and with disease activity in relapsing−remitting MS. However, less is known about the effect of smoking on disease progression in progressive MS. Here...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of neurology 2017-04, Vol.24 (4), p.624-630
Hauptverfasser: Javizian, O., Metz, L. M., Deighton, S., Koch, M. W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and purpose The modifiable risk factor cigarette smoking has been associated with an increased risk of developing multiple sclerosis (MS) and with disease activity in relapsing−remitting MS. However, less is known about the effect of smoking on disease progression in progressive MS. Here the association between cigarette smoking and disability accumulation in primary progressive MS (PPMS) is investigated. Methods Kaplan–Meier survival analyses and Cox proportional hazard modelling were used to investigate the influence of cigarette smoking on the risk of reaching Expanded Disability Status Scale (EDSS) 4 and 6 as well as the time from EDSS 4 to 6 in patients with PPMS. Results In all, 416 patients with PPMS and available smoking history were identified. Median time to EDSS 4 was 4 years in ever‐smokers and 5 years in never‐smokers (P = 0.27), and it was 9 years to EDSS 6 in both ever‐smokers and never‐smokers (P = 0.48). Smokers were not at increased risk of faster progression to EDSS 4, 6 and from EDSS 4 to 6. Age at disease onset was the strongest risk factor for progression to EDSS 4, 6 and from EDSS 4 to 6. Conclusions Our investigation of a large and well‐characterized population based PPMS cohort suggests that cigarette smoking does not influence disability accumulation in PPMS. Our findings support the idea that PPMS is driven by different underlying pathomechanisms than relapsing−remitting MS.
ISSN:1351-5101
1468-1331
DOI:10.1111/ene.13262